-
The U.S. medical eligibility criteria for contraceptive Use is a newly available, free, evidence-based resource for clinicians. This resource provides guidance to aid contraceptive decision-making for women (and men) with comorbidities.
-
The primary purpose of this study was to develop a gene expression profile of BRCA dysfunction ("BRCAness"), which could be used to discriminate sporadic ovarian cancer patients with or without dysfunction to the homologous repair pathway and correlate whether this profile would describe sensitivity to platinum-based chemotherapy and pharmacological inhibition of poly-ADP ribose polymerase (PARP).
-
In 1972, liggins and howie demonstrated that antenatal corticosteroids (ACS) stimulated the production of surfactant in premature human fetuses.
-
National estimates of contraceptive use and method choice from the most recent 2006-2008 cycle of the National Surveys of Family Growth (NSFG) were compared to earlier estimates based on the 1982, 1995, and 2002 surveys.
-
Heads up for reproductive health and family planning clinics in California and Nevada: The Female Health Co.'s free FC2 Female Condom Experience Program is headed your way. Deadline for applications from clinics in the two states is Aug. 31, 2010, says Rebecca Kizaric, training manager for the Chicago-based company.
-
For 50 years, women have had a reliable form of birth control in the form of the combined oral contraceptive pill. What has emerged in the same time period for men?
-
-
Research indicates that women are at risk for heightened HIV infection during pregnancy, but what about their partners?
-
Clinicians face challenges when it comes to detecting ovarian cancer: 70% of women with ovarian cancer are diagnosed with advanced disease.
-
Strive to keep your practice up-to-date in 2010 with the publication of the U.S. Medical Eligibility Criteria for Contraceptive Use.